Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

November 20, 2017

IN RE OCULAR THERAPEUTIX, INC. SECURITIES LITIGATION

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. May 01, 2019

    Ocular Shakes Investor Suit Over FDA Approval Of Eye Drug

    Ocular Therapeutix Inc. escaped a proposed class action Tuesday after a Massachusetts federal judge found that the investors who accuse the biopharmaceutical company of misleading them about federal approval for an eye pain reliever failed to prove that alleged misstatements were actually false.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login